NYSE · HUM · Healthcare Plans
Humana Inc. (HUM) stock analysis
- HUM gained 14.4% over the past month versus 0.0% for the S&P 500, ranking 23rd of 497 S&P 500 stocks.
- Over 12 months it returned +51.1%, 35.3 points ahead of the S&P 500, and trades 1.9% below its 52-week high.
- In the last 30 days 6 analysts raised earnings estimates and 0 cut; forward EPS moved +3.1% (+6.6% over 90 days).
- It sits in the Health insurers segment of the Healthcare Value Chain, where the 1-month median return is +11.2%.
- The daily chart reads Intermediate uptrend · Trend advance (since Oct 20, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 20, 2026
- Close above EMA20 above EMA50
- EMA50 rose over the last ten sessions
72 occurrences in 10 years. The median move over the next 20 sessions was 0.0%, positive 50% of the time, against +1.0% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
23 analysts cover the stock
Where it sits in the supply chain
Healthcare Value Chain · Payers
Commercial, Medicare Advantage and Medicaid plans; the medical cost ratio and government rates matter most, and UnitedHealth usually reports first.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.